Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | D594G |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | BRAF D594G lies within the protein kinase domain of the Braf protein (UniProt.org). D594G demonstrates increased transforming ability in one of two cell lines in culture (PMID: 29533785), however, results in impaired Braf kinase activity, but leads to increased activation of Erk signaling through Craf in cell culture (PMID: 18794803, PMID: 28783719), and also demonstrates Craf activation similar to wild-type Braf, but with enhanced dimerization and the ability to bypass autoinhibitory autophosphorylation in in vitro assays (PMID: 31929109), and confers Mek inhibitor resistance in culture (PMID: 18794803), and therefore, is predicted to lead to a loss of Braf protein function. |
Associated Drug Resistance | Y |
Category Variants Paths |
BRAF mutant BRAF D594X BRAF D594G BRAF mutant BRAF inact mut BRAF D594G |
Transcript | NM_004333.6 |
gDNA | chr7:g.140753354T>C |
cDNA | c.1781A>G |
Protein | p.D594G |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_004333.5 | chr7:g.140753354T>C | c.1781A>G | p.D594G | RefSeq | GRCh38/hg38 |
NM_004333 | chr7:g.140753354T>C | c.1781A>G | p.D594G | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140753354T>C | c.1781A>G | p.D594G | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140753354T>C | c.1781A>G | p.D594G | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140753354T>C | c.1781A>G | p.D594G | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140753354T>C | c.1781A>G | p.D594G | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140753354T>C | c.1781A>G | p.D594G | RefSeq | GRCh38/hg38 |
XM_005250045 | chr7:g.140753354T>C | c.1781A>G | p.D594G | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|